文献速递肝病

瞬时弹性成像在初治原发性胆汁性胆管炎诊断时评估纤维化的准确性:双截断值方法

Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach.
PubMed 文献 · Hepatology · 2021-05-28

本研究纳入167例初治原发性胆汁性胆管炎(PBC)患者,在诊断时行肝活检,并在12周内完成振动控制瞬时弹性成像(VCTE)。推导队列126例中,VCTE诊断进展期纤维化(AF,Ludwig分期≥III)的AUROC为0.89;LSM≤6.5 kPa可排除AF(NPV=0.94),LSM>11.0 kPa可确认AF(PPV=0.89),外部验证队列91例结果一致。

要点

  • 初治PBC诊断时,LSM≤6.5 kPa可排除进展期纤维化,NPV=0.94。
  • LSM>11.0 kPa可确认进展期纤维化,PPV=0.89。
  • LSM介于6.5–11.0 kPa时VCTE不可靠,应考虑肝活检。

核心结论

  • 在初治PBC患者中,LSM≤6.5 kPa和>11.0 kPa两个截断值可在诊断时分别排除和确认进展期纤维化,并获外部验证。

研究设计与样本

  • 多中心研究,纳入167例初治PBC患者,诊断时行肝活检,VCTE在肝活检12周内完成,肝活检由两名盲法专家病理学家按Ludwig系统评分。
  • 推导队列126例具有有效LSM和肝活检结果,外部验证队列91例PBC患者。

主要发现

  • 推导队列中VCTE诊断AF(Ludwig分期≥III)的AUROC为0.89。
  • LSM≤6.5 kPa排除AF的NPV=0.94,LSM>11.0 kPa确认AF的PPV=0.89,错误率=5.6%。
  • 外部验证队列NPV=0.93,PPV=0.89,错误率=8.6%。
  • 多变量分析显示仅纤维化分期影响LSM,BMI和肝脏生化指标与LSM无关联。

关键数值与推荐

  • AF定义为Ludwig分期≥III。
  • LSM≤6.5 kPa用于排除AF,NPV=0.94(推导队列)和0.93(验证队列)。
  • LSM>11.0 kPa用于确认AF,PPV=0.89(推导队列和验证队列)。
  • LSM介于6.5和11.0 kPa之间时VCTE不可靠,应评估肝活检以准确分期。

临床怎么用

  • 初治PBC诊断时可用VCTE评估纤维化:LSM≤6.5 kPa排除进展期纤维化,LSM>11.0 kPa确认进展期纤维化。
  • LSM在6.5–11.0 kPa之间时VCTE结果不可靠,应考虑肝活检进行准确疾病分期。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Liver fibrosis holds a relevant prognostic meaning in primary biliary cholangitis (PBC). Noninvasive fibrosis evaluation using vibration-controlled transient elastography (VCTE) is routinely performed. However, there is limited evidence on its accuracy at diagnosis in PBC. We aimed to estimate the diagnostic accuracy of VCTE in assessing advanced fibrosis (AF) at disease presentation in PBC. APPROACH AND RESULTS: We collected data from 167 consecutive treatment-naïve PBC patients who underwent liver biopsy (LB) at diagnosis at six Italian centers. VCTE examinations were completed within 12 weeks of LB. Biopsies were scored by two blinded expert pathologists, according to the Ludwig system. Diagnostic accuracy was estimated using the area under the receiver operating characteristic curves (AUROCs) for AF (Ludwig stage ≥III). Effects of biochemical and clinical parameters on liver stiffness measurement (LSM) were appraised. The derivation cohort consisted of 126 patients with valid LSM and LB; VCTE identified patients with AF with an AUROC of 0.89. LSM cutoffs ≤6.5 and >11.0 kPa enabled to exclude and confirm, respectively, AF (negative predictive value [NPV] = 0.94; positive predictive value [PPV] = 0.89; error rate = 5.6%). These values were externally validated in an independent cohort of 91 PBC patients (NPV = 0.93; PPV = 0.89; error rate = 8.6%). Multivariable analysis found that the only parameter affecting LSM was fibrosis stage. No association was found with BMI and liver biochemistry. CONCLUSIONS: In a multicenter study of treatment-naïve PBC patients, we identified two cutoffs (LSM ≤6.5 and >11.0 kPa) able to discriminate at diagnosis the absence or presence, respectively, of AF in PBC patients, with external validation. In patients with LSM between these two cutoffs, VCTE is not reliable and liver biopsy should be evaluated for accurate disease staging. BMI and liver biochemistry did not affect LSMs.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Cristoferi L, Calvaruso V, Overi D, et al. Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach. Hepatology. 2021. PMID: 33724515. doi:10.1002/hep.31810

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。